NEMF

NEMF (RQC2) is a core subunit of the ribosome-associated quality control (RQC) machinery that recognizes 60S large ribosomal subunits carrying stalled nascent polypeptide chains and commits those chains to degradation [PMID:26943317, PMID:bio_10.1101_2024.08.24.608776]. On the stalled 60S, NEMF performs two coupled functions: it stabilizes recruitment of the RING E3 ubiquitin ligase Listerin/Ltn1 to promote ubiquitination and proteasomal targeting of the nascent chain [PMID:26943317, PMID:bio_10.1101_2024.10.17.618946], and it appends non-templated C-terminal Ala/Thr ('CAT') tails to the chain, which extrude buried lysines from the exit tunnel to enable ubiquitination [PMID:26943317, PMID:bio_10.1101_2024.08.24.608776]. A cryo-EM structure of the RQC complex shows that CAT-tailing depends on Rqc2/NEMF positioning tRNA at the ribosomal A site, and a mutation in this interface limits CAT-tailing while promoting peptide release (PMID:40187343). CAT-tailing is context-dependent: when ubiquitination is inefficient, CATylated chains are routed to detergent-insoluble, amyloid-like aggregates [PMID:26943317, PMID:bio_10.1101_2024.08.24.608776], and exit-tunnel sequence features such as poly-tryptophan tracts block CAT-tailing to permit Rqc2-independent clearance (PMID:33511411). NEMF also directs substrate-specific degradation routes beyond the canonical cytosolic pathway, including a Listerin-independent mitochondrial route in which poly-Ala-tailed nuclear-encoded mitochondrial substrates are handed to the E3 ligase Pirh2 and the protease ClpXP (PMID:38412092), and an ER translocation-associated quality control route in which CAT-tail composition determines clearance via unconventional ERAD with Golgi retrieval versus lysosomal degradation (PMID:40257401). Mutations that selectively impair NEMF CAT-tailing cause progressive motor neuron degeneration in mice and juvenile neuromuscular disease in humans (PMID:32934225).

1. 2016 High

   Established the dual molecular function of NEMF on stalled 60S subunits—both stabilizing Listerin and adding a non-templated C-terminal tail—answering how a stalled nascent chain is marked for clearance versus aggregation.

   Evidence Yeast genetics and biochemistry with Ltn1 inactivation, detergent-solubility fractionation, and ubiquitylation-lysine mutagenesis

   PMID:26943317

   Open questions at the time

   • Did not resolve the structural basis of tRNA-dependent tail addition
   • Mammalian relevance not directly tested
2. 2020 High

   Separated NEMF's two activities in vivo by showing that CAT-tailing—not Listerin recruitment—is the activity whose loss drives neurodegeneration, linking RQC tail-addition to mammalian neuronal homeostasis and human disease.

   Evidence Three independent mouse models, yeast equivalent mutations for CAT-tailing defect, and human loss-of-function variant identification

   PMID:32934225

   Open questions at the time

   • Did not define which neuronal substrates are CAT-tailed
   • Mechanism linking aggregation to neuronal death not established
3. 2020 Medium

   Provided cellular evidence that NEMF supports neuron development beyond degradation, showing knockdown impairs axon outgrowth and synapse formation.

   Evidence Immunofluorescence and morphology of Nemf-knockdown mouse primary cortical neurons

   PMID:33048237

   Open questions at the time

   • Single knockdown assay with morphological readout only
   • No connection to RQC pathway placement
   • No rescue with CAT-tailing-dead mutant
4. 2021 Medium

   Showed CAT-tailing is gated by nascent-chain identity in the exit tunnel, with poly-tryptophan blocking tail addition and enabling Rqc2-independent Listerin-driven clearance.

   Evidence Yeast CAT-tail reporter assays with distinct stalling sequences and Rqc2 deletion analysis

   PMID:33511411

   Open questions at the time

   • Mechanism by which exit-tunnel sequence blocks tail addition unresolved
   • Not tested in mammalian system
5. 2024 Medium

   Defined a Listerin-independent mitochondrial RQC branch in which NEMF poly-Ala-tails partially imported mitochondrial nascent chains for Pirh2/ClpXP-mediated degradation, explaining how RQC operates when lysine access is restricted by the translocon.

   Evidence Mammalian mitochondrial RQC reporters, Co-IP of Pirh2 and ClpXP, loss-of-function and mitochondrial integrity assays

   PMID:38412092

   Open questions at the time

   • Single lab without independent replication
   • Direct NEMF–Pirh2 interaction interface not mapped
   • Co-IP not reciprocally validated
6. 2024 Medium

   Linked NEMF mutant protein to a nucleocytoplasmic transport defect, showing mutant NEMF traps Importin-β and disrupts TDP43/RanGAP1/Ran localization, suggesting a gain-of-function pathology distinct from RQC loss.

   Evidence Two mouse models, nuclear import assays, co-localization, Co-IP of Importin-β with mutant NEMF, and pharmacological Importin-β inhibition

   PMID:39312574

   Open questions at the time

   • Relationship to CAT-tailing activity unresolved
   • Whether transport defect is cause or consequence of aggregation unclear
   • Single lab
7. 2025 High

   Resolved the structural basis of CAT-tailing, showing Rqc2/NEMF positions A-site tRNA on the 60S and that a point mutation at this interface limits tail addition and favors peptide release.

   Evidence Cryo-EM structure of the RQC complex with genetic screen and functional CAT-tailing assays of the F340I allele

   PMID:40187343

   Open questions at the time

   • Mammalian structural conservation not directly addressed
   • Dynamics of repeated tRNA loading during tail elongation not captured
8. 2025 High

   Showed NEMF CAT-tailing directs ER translocation-associated QC substrates, with CAT-tail composition (AT- vs AG-rich) determining routing to unconventional ERAD with Golgi retrieval versus lysosomal degradation.

   Evidence Genome-wide CRISPR screen, live-cell imaging, ER nonstop and poly(A) stalling reporters, NEMF KO, and CAT-tail mimetics

   PMID:40257401

   Open questions at the time

   • Reader that decodes CAT-tail composition into routing not identified
   • Generality across endogenous substrates not established
9. 2025 Low

   Placed RPL26 UFMylation upstream of and independent from NEMF/Listerin at ER-stalled ribosomes, indicating UFMylation marks the 60S-peptidyl-tRNA complex separately from NEMF-dependent chain clearance.

   Evidence ER-targeted stalling reporters with combined NEMF/LTN1 loss-of-function and UFMylation analysis (preprint)

   PMID:bio_10.1101_2025.01.17.633636

   Open questions at the time

   • Preprint, single lab, not independently confirmed
   • No biochemical reconstitution of the NEMF–UFMylation relationship
   • Functional consequence of coordination not defined

• How CAT-tail composition is read by downstream machinery to select among aggregation, proteasomal, mitochondrial, ERAD, and lysosomal fates, and how this decoding fails in NEMF-driven neurodegeneration, remains unresolved.
• No identified CAT-tail reader or sensor
• Causal link between CAT-tail defects and specific neuronal substrate aggregation unmapped